Type 2 diabetes is on the rise in the U.S.--and so is TV ad spending for drugs to treat the condition. New medicines, along with increased marketing budgets on older meds, more than doubled diabetes ...

The top 40 pharma companies spent almost a quarter-billion on TV advertising ($231 million) in September, airing ads more than 91,000 times. Of those spots, more than 20% (18,753) ran in primetime.

TITUSVILLE, N.J., Oct. 30, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved INVOKANA ® ...

Jardiance (empagliflozin) and Invokana (canagliflozin) are prescription oral tablets used to treat high blood sugar caused by type 2 diabetes. They’re also prescribed to lower the risk of certain ...

Sales of the diabetes drug Invokana have spiked to more than $1 billion in the past year. First, a bit of background Invokana, which got Food and Drug Administration approval in 2013, helps diabetes ...